NCT07618715
Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participants
Not Yet Recruiting
PHASE1Ages 18–45InterventionalTreatmentNeurodawn Pharmaceutical Co., Ltd.
~11 participants
Updated 2026-06-01 on ClinicalTrials.gov
What's tested:Y-4 tabletPregabalin capsuleRiluzole tablet
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cmax
Measured over On Day1-4、Day8-11、Day15-18 of observation period.
+2 more outcomes measured
Conditions
Where it's being run
1 sites across 1 statesNew Jersey1
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- CmaxOn Day1-4、Day8-11、Day15-18 of observation period.
Maximum observed concentration, it was obtained directly from the measured plasma concentration-time data;
- AUC0-tOn Day1-4、Day8-11、Day15-18 of observation period.
Area under the concentration-time curve from time zero to the last detectable concentration
- AUC0-∞On Day1-4、Day8-11、Day15-18 of observation period.
Area under the concentration-time curve from time 0 to infinity (extrapolated).